Cargando…

Dual-targeting nanoparticle vaccine elicits a therapeutic antibody response against chronic hepatitis B

Chronic hepatitis B is caused by prolonged infection with the hepatitis B virus (HBV), which can substantially increase the risk of developing liver disease. Despite the development of preventive vaccines against HBV, a therapeutic vaccine inducing an effective antibody response still remains elusiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Wenjun, Zhou, Xiaoxiao, Bian, Yingjie, Wang, Shan, Chai, Qian, Guo, Zhenqian, Wang, Zhenni, Zhu, Ping, Peng, Hua, Yan, Xiyun, Li, Wenhui, Fu, Yang-Xin, Zhu, Mingzhao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7223715/ https://www.ncbi.nlm.nih.gov/pubmed/32123380 http://dx.doi.org/10.1038/s41565-020-0648-y

Ejemplares similares

Ferritin nanoparticle-based SARS-CoV-2 RBD vaccine induces a persistent antibody response and long-term memory in mice
por: Wang, Wenjun, et al.
Publicado: (2021)

Lassa virus glycoprotein nanoparticles elicit neutralizing antibody responses and protection
por: Brouwer, Philip J.M., et al.
Publicado: (2022)

Challenges to the development of vaccines to hepatitis C virus that elicit neutralizing antibodies
por: Drummer, Heidi E.
Publicado: (2014)

HMGB1/GPC3 dual targeting vaccine induces dendritic cells-mediated CD8(+)T cell immune response and elicits potential therapeutic effect in hepatocellular carcinoma
por: Shi, Xiaoqing, et al.
Publicado: (2023)

Dual targets of lethal apoptosis and protective autophagy in liver cancer with periplocymarin elicit a limited therapeutic effect
por: Hao, Yuanyuan, et al.
Publicado: (2023)

Elicitation of Neutralizing Antibody Responses to HIV-1 Immunization with Nanoparticle Vaccine Platforms
por: Murji, Amyn A., et al.
Publicado: (2021)

Perfluorooctyl bromide nanoemulsions holding MnO(2) nanoparticles with dual-modality imaging and glutathione depletion enhanced HIFU-eliciting tumor immunogenic cell death
por: Kuai, Xinping, et al.
Publicado: (2022)

Dual targeting nanoparticles for epilepsy therapy
por: Hou, Qinghong, et al.
Publicado: (2022)

Mechanism of a COVID-19 nanoparticle vaccine candidate that elicits a broadly neutralizing antibody response to SARS-CoV-2 variants
por: Zhang, Yi-Nan, et al.
Publicado: (2021)

Mechanism of a COVID-19 nanoparticle vaccine candidate that elicits a broadly neutralizing antibody response to SARS-CoV-2 variants
por: Zhang, Yi-Nan, et al.
Publicado: (2021)

Neutralizing monoclonal antibodies elicited by mosaic RBD nanoparticles bind conserved sarbecovirus epitopes
por: Fan, Chengcheng, et al.
Publicado: (2022)

Integration of Dual Targeting and Dual Therapeutic Modules Endows Self-Assembled Nanoparticles with Anti-Tumor Growth and Metastasis Functions
por: Chen, Biao, et al.
Publicado: (2021)

A Powassan virus domain III nanoparticle immunogen elicits neutralizing and protective antibodies in mice
por: Malonis, Ryan J., et al.
Publicado: (2022)

Pseudovirus Nanoparticles Displaying Plasmodium Circumsporozoite Proteins Elicited High Titers of Sporozoite-Binding Antibody
por: Xia, Ming, et al.
Publicado: (2023)

Targeting of Hepatic Macrophages by Therapeutic Nanoparticles
por: Colino, Clara I., et al.
Publicado: (2020)

Omicron subvariants escape antibodies elicited by vaccination and BA.2.2 infection
por: Yao, Lin, et al.
Publicado: (2022)

A novel method for synthetic vaccine construction based on protein assembly
por: Liu, Zhida, et al.
Publicado: (2014)

Profiles of Human Serum Antibody Responses Elicited by Three Leading HIV Vaccines Focusing on the Induction of Env-Specific Antibodies
por: Vaine, Michael, et al.
Publicado: (2010)

Zika virus infection elicits auto-antibodies to C1q
por: Koma, Takaaki, et al.
Publicado: (2018)

The Neutralizing Antibody Response Elicited by Tembusu Virus Is Affected Dramatically by a Single Mutation in the Stem Region of the Envelope Protein
por: Lv, Junfeng, et al.
Publicado: (2020)

Achieving highly efficient aggregation-induced emission, reversible and irreversible photochromism by heavy halogen-regulated photophysics and D–A molecular pattern-controlled photochemistry of through-space conjugated luminogens
por: Xiong, Zuping, et al.
Publicado: (2021)

Recombinant Encephalomyocarditis Viruses Elicit Neutralizing Antibodies against PRRSV and CSFV in Mice
por: Zhu, Shu, et al.
Publicado: (2015)

Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2
por: Walls, Alexandra C., et al.
Publicado: (2020)

Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2
por: Walls, Alexandra C., et al.
Publicado: (2020)

Designed nanoparticles elicit cross-reactive antibody responses to conserved influenza virus hemagglutinin stem epitopes
por: McCraw, Dustin M., et al.
Publicado: (2023)

Epitope-Directed Antibody Elicitation by Genetically Encoded Chemical Cross-Linking Reactivity in the Antigen
por: Zhu, Chaoyang, et al.
Publicado: (2023)

The emergence of AntibodyPlus: the future trend of antibody-based therapeutics
por: Zhu, Yong, et al.
Publicado: (2022)

Transforming Porous Silica Nanoparticles into Porous Liquids with Different Canopy Structures for CO(2) Capture
por: Sheng, Lisha, et al.
Publicado: (2022)

Exploration of a Sequential Gp140-Gp145 Immunization Regimen with Heterologous Envs to Induce a Protective Cross-Reactive HIV Neutralizing Antibody Response In Non-human Primates
por: Ding, Xiangqing, et al.
Publicado: (2021)

Single-cell landscape analysis reveals distinct regression trajectories and novel prognostic biomarkers in primary neuroblastoma
por: Liu, Qingqing, et al.
Publicado: (2022)

An epitope encoded by uORF of RNF10 elicits a therapeutic anti-tumor immune response
por: Zeng, Lili, et al.
Publicado: (2023)

Immunization of N terminus of enterovirus 71 VP4 elicits cross-protective antibody responses
por: Zhao, Miao, et al.
Publicado: (2013)

Increased resistance of SARS-CoV-2 Omicron variant to neutralization by vaccine-elicited and therapeutic antibodies
por: Tada, Takuya, et al.
Publicado: (2022)

Fc-Dependent Immunomodulation Induced by Antiviral Therapeutic Antibodies: New Perspectives for Eliciting Protective Immune Responses
por: Pelegrin, Mireia, et al.
Publicado: (2022)

Biotransformation of rare earth oxide nanoparticles eliciting microbiota imbalance
por: Zheng, Huizhen, et al.
Publicado: (2021)

The self-assembled nanoparticle-based trimeric RBD mRNA vaccine elicits robust and durable protective immunity against SARS-CoV-2 in mice
por: Sun, Wenqiang, et al.
Publicado: (2021)

The diagnosis of hepatic fibrosis by magnetic resonance and near-infrared imaging using dual-modality nanoparticles
por: Li, Yunfang, et al.
Publicado: (2018)

Development of a 7-miRNA prognostic signature for patients with bladder cancer
por: Xv, Yingjie, et al.
Publicado: (2022)

NIR Laser Responsive Nanoparticles for Ovarian Cancer Targeted Combination Therapy with Dual-Modal Imaging Guidance
por: Zhao, Jiawen, et al.
Publicado: (2021)

Multimerization of Ebola GPΔmucin on protein nanoparticle vaccines has minimal effect on elicitation of neutralizing antibodies
por: Powell, Abigail E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5jsmf6v50nld89mfmifsnmngjv